Medication info
Tenelli Duo Extended-Release Tablet 10/750 mg

Tenelli Duo Extended-Release Tablet 10/750 mg

Prescription medicationTablet경구
Ingredient · strength
Metformin Hydrochloride›750mg / 1 tabletTeneligliptin Ditosylate Dihydrate›18.92mg / 1 tablet
Manufacturer / importer
지엘파마(주)
Appearance
Yellow oval-shaped extended-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202202720 · Approved 2022.07.01 · Insurance code 649702870

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who takes it
Adults
Adult dose
The dosage of this medication is determined based on each patient's current treatment plan, efficacy, and tolerance. Typically, it is administered once daily with the evening meal, and the dosage is adjusted gradually to reduce gastrointestinal side effects related to metformin. For this medication 20/1000 mg extended-release tablets, take one tablet once a day. Patients taking this medication 10/750 mg or 10/500 mg extended-release tablets should take two tablets once a day.

Ingredients

Manufacturer
지엘파마(주)

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes by combining teneligliptin and metformin. It supports effective management of blood sugar when combined with diet and exercise therapy. Therefore, it is used to improve blood sugar control.

How to take

Adult dose

The dosage of this medication is determined based on each patient's current treatment plan, efficacy, and tolerance. Typically, it is administered once daily with the evening meal, and the dosage is adjusted gradually to reduce gastrointestinal side effects related to metformin. For this medication 20/1000 mg extended-release tablets, take one tablet once a day. Patients taking this medication 10/750 mg or 10/500 mg extended-release tablets should take two tablets once a day.

Precautions

This medication is used in the treatment of diabetes and contains the ingredients metformin and teneligliptin. When taking this medication, there is a risk of a rare complication known as severe lactic acidosis, so it should not be administered to patients with renal impairment, liver dysfunction, congestive heart failure, or acute infections. Additionally, patients who are scheduled to undergo tests using iodinated contrast agents should discontinue the medication and verify normal kidney function before restarting. Caution is advised when taking this medication with insulin or sulfonylurea drugs, as there is a risk of hypoglycemia. This medication may occasionally cause side effects including constipation, abdominal pain, dizziness, and hypoglycemia, and in case of serious adverse reactions such as acute pancreatitis, interstitial pneumonia, or skin rash, immediate medical attention should be sought. During treatment, it is important to regularly monitor kidney function, liver function, and blood tests for any abnormalities. It is advisable for women who are pregnant or may become pregnant, as well as nursing mothers, to avoid this medication. Extra caution is required for children and the elderly; elderly patients often have decreased kidney function, necessitating dosage adjustments and regular monitoring. In cases of overdose, appropriate treatment should be sought at a medical facility immediately, and hemodialysis may be beneficial. The risk of lactic acidosis increases if this medication is taken with alcohol, so alcohol consumption should be avoided. Furthermore, individuals taking this medication should be well-informed about hypoglycemia symptoms and their management, and should exercise caution when performing dangerous tasks such as driving or operating heavy machinery.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in mouth/eyes, shortness of breath or difficulty breathing, asthma attack, cough with fever and breathing abnormalities, yellowing of the skin or eyes (jaundice), profound weakness, sudden and intense headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary

Mild side effects

  • Constipation
  • dizziness
  • abdominal distension
  • discomfort in the abdomen
  • nausea
  • abdominal pain
  • bloating
  • stomatitis
  • gastric polyp
  • colonic polyp
Show 20 more
  • duodenal ulcer
  • gastroesophageal reflux
  • diarrhea
  • decreased appetite
  • increased amylase
  • increased lipase
  • increased AST (GOT)
  • increased ALT (GPT)
  • increased GGT
  • increased ALP
  • proteinuria
  • ketonuria
  • occult hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • increased CK (CPK)
  • blood

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1°C and 30°C to ensure the medication's effectiveness is safely preserved.

Appearance and packaging

Appearance

Yellow oval-shaped extended-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.